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Background and Objectives: During the pandemic, the growing influence of social
media, accessibility of over-the-counter medications, and fear of contracting the virus
may have led to self-medication practices among the general public. Medical students
are prone to such practices due to relevant background knowledge, and access to drugs.
This study was carried out to determine and analyze the prevalence of self-medication
practices among medical students in Pakistan.
Materials and Methods: This descriptive, cross-sectional study was conducted
online in which the participants were asked about the general demographics, their selfmedication practices and the reasons to use. All participants were currently enrolled
in a medical college pursuing medical or pharmacy degree. Non-probability sampling
technique was used to recruit participants.
Results: A total of 489 respondents were included in the final analysis. The response
rate was 61%. Majority of the respondents were females and 18–20 years of age. Selfmedication was quite prevalent in our study population with 406 out of 489 individuals
(83.0%) were using any of the drugs since the start of pandemic. The most commonly
utilized medications were Paracetamol (65.2%) and multivitamins (56.0%). The reasons
reported for usage of these medications included cold/flu, or preventive measures
for COVID-19. The common symptoms reported for self-medication included fever
(67.9%), muscle pain (54.0%), fatigue (51.7%), sore throat (46.6%), and cough (44.4%).
Paracetamol was the most commonly used drug for all symptoms. Female gender, being
in 3rd year of medical studies, and individuals with good self-reported health were found
more frequent users of self-medication practices.
Conclusion: Our study revealed common self-medication practices among medical
and pharmacy students. It is a significant health issue especially during the pandemic
times, with high consumption reported as a prevention or treating symptoms
of COVID-19.
Keywords: self-medication, medical students, COVID-19, pandemic, public health, Pakistan
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INTRODUCTION

study reports the prevalence of self-medication in the highly
affected medical student population in Pakistan—the future of
the healthcare system. It is important to assess self-medication
practices among medical students, because they have relevant
knowledge, and are more likely to access to prescription as well
as OTC drugs. Low tendency to consult health professionals,
reliance on the internet for information on background medical
knowledge, and treating self-diagnosed illnesses could be factors
that promotes self-medication practice among medical students.
The primary objective was to determine and analyze the
prevalence of self-medication practices among medical students
for respiratory symptoms, from the onset of first COVID-19
symptom or in case of being positively tested for COVID19. We further assessed the self-medicated drugs used for
respiratory problems during the pandemic. A secondary aim
was to evaluate the factors associated with self-medication of
various drugs among medical students during the COVID-19
pandemic in Pakistan. This will allow the health ministries and
educational administrations alike to undertake measures and
address the gap of health negligence that can result from selfmedication practices.

The Coronavirus 2019 (COVID-19) was declared a pandemic by
the World Health Organization on January 30th, 2020 (1). As
of October 22nd, 2021, the global crisis has affected 242 million
individuals and claimed over 4.9 million lives (2).
With clinical trials of multiple drugs in the pipeline, there
are no definitive treatments with confirmed evidence against the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV2). Anti-malarial drugs, hydroxychloroquine, and chloroquine
received emergency approval to treat prophylaxis in COVID-19
when a small non-randomized trial was initially promising (3).
It was soon labeled controversial as randomized studies depicted
an increased risk-to-benefit ratio (4). However, rapid medical
research has developed, and massively rolled out COVID19 vaccines prevented the adverse effects from symptoms of
the disease in affected individuals (5). It is envisaged that
vaccine advent and procurement by developed countries will
soon create global inequity as middle-to-low income nations
struggle to vaccinate healthcare workers and the older population
(6). Economic recession in developing countries, like Pakistan
has only managed to fully vaccinate less than half of its
population (7).
The third wave of coronavirus had peaked, yet Pakistan’s
overburdened healthcare system reached a 90% occupancy of
ventilators and hospital beds (8). Travel restrictions, oxygen
shortage, and the risk of contracting the virus from crowded
clinics and hospitals have inculcated fear in the public, allowing
a nation prone to self-medication to rely more heavily on
self-diagnosis (9, 10). Self-medication is the administering of
medicines to treat self-recognized symptoms, psychological
ailments, and first aid based on prior knowledge, without
consulting a physician (11). The growing influence of social
media has let individuals explore COVID-related symptoms, pain
keywords, and treatments worldwide, as well as in Pakistan,
as revealed by an infodemiological study on Google trends
(12). Adding to this is the availability of over the counter
(OTC) drugs in pharmacies across Pakistan which has been the
highest contributor to a self-medicating prevalence of 81% in the
populous Karachi. Easily accessible drugs in pharmacies across
Pakistan range from analgesics, antibiotics, anti-diarrheal agents,
antihistamines, antipyretics, cough-suppressants, vitamins to
herbal medicines and homeopathy (10, 13). Though the primary
reason was affordability, the greatest driver (47.8%) of selfmedication was the belief that the illness was insignificant. This
stems from poor health literacy amongst the general public which
is easily influenced by the media (10). It is also well noted that
preference for self-medication is cultural practice in Pakistan.
The positive and negative effects of self-medication of Sanna
Makki, a herbal laxative, which was widely used as a COVID-19
cure after mass-circulation on WhatsApp was a well-publicized
example (14). The risks attached to self-medicated drugs include
incorrect and improper dosage, and antibiotic abuse leading to
drug resistance (15).
A trending worldwide practice of self-medication does not
have enough literature on an ongoing pandemic, except studies
conducted in Peru and Saudi Arabia (16, 17). However, no
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MATERIALS AND METHODS
Study Design
This descriptive, cross-sectional study was conducted online
from January 25th to February 20th, 2021. The design of
the study and sample size was modified according to the
pilot study carried out from December 11th to December
15th, 2020, under the expertise of professors and doctors. The
questionnaire was developed in English, on Google survey, and
distributed through social media platforms. The online survey
questions were obtained after a thorough literature search and
assessing the validity and reliability (16, 17). The responses
were made anonymous to maintain confidentiality and reliability.
Each participant received an email of their response to avoid
duplication of data. Clarification of the contents and the purpose
of the study were explained at the start of the survey followed
by an informed consent. Data was anonymized and only the lead
investigator had access to the responses.

Development of Survey Questionnaire and
Operationalization of Variables
The questionnaire included a total of 11 questions. Seven
questions were dedicated to the general demographics including
the city of residence, gender, age, marital status, level of
education/medical, and comorbid conditions. The next 4
questions were based on self-medication of drugs for prevention
and treatment of respiratory symptoms: drug selection, reasoning
for self-medication, symptoms they were looking to improve,
and if any of the drugs improved those symptoms. The
participants were asked if they consulted any physician
before starting these medications, were they been using these
medications before COVID-19 pandemic, and do they have
any comorbid conditions that warrant the use of these
medications. All these questions if answered as a No have
been considered as self-medication during the pandemic. The
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region, presence of comorbid conditions, and self-reported
health as control variables. Categorical variables were assessed
using frequencies and percentages, through univariate analysis.
Analytical statistics were performed with 95% confidence
intervals (CI) and odds ratios (OR), which were obtained using
logistic regression.

drugs listed in the survey included acetaminophen, ibuprofen,
azithromycin, hydroxychloroquine, ivermectin, doxycycline,
antivirals (lopinavir, ritonavir, remdesivir, and others), cetirizine,
multivitamin compounds or any other drug (open question) for
respiratory symptoms. All drugs were classified according to the
Anatomical Therapeutic Chemical (ATC) (18). This selection
of drugs was based on the existing literature, and reports
from the local media. COVID-19 can present with a range
of symptoms. Frequently reported symptoms were obtained
from CDC’s guidelines (19). The list of symptoms included
fever, fatigue, cough, muscle ache, nasal congestion, sore throat,
headache, breathing difficulty, no symptom, and other symptom
(open question). Anosmia was omitted as being controversial at
the time of inception of this study (16). To assess the reason for
drug use, participants had seven options listed as cold/flu, no
symptoms, COVID-19 prevention, had COVID-19 symptoms,
COVID-19 positive, consume the drug regularly, other reason
(open question). The following 5-point Likert scale was used to
identify and list the improvement in symptoms if any: improved
all symptoms, improved most of the symptoms, improved a few
of the symptoms, improved only one symptom, did not alleviate
any of the symptoms.

RESULTS
A total of 374 medical and 115 pharmacy students were included
in the final analysis. The response rate was 61%. Majority of the
respondents were of 18–20 years of age (58.5%). More than threefourths were females. 34.0% of medical students were in first year,
20.6% in second year, 20.3% in third year, 13.9% in fourth year,
and 11.2% were in final year of their medical education. Most
respondents were from province Sindh and Punjab (combined
85.7%). Only 4.5% reported previous comorbid conditions, while
majority (60.5%) were in good state of self-reported health. While
reporting the risk of acquiring COVID-19 infection, 43.8% were
unbothered. Another 38.0% admitted mild risk while only 2.9%
reported severe risk. 15.3% of participants were already infected
with the virus. The socio-demographic characteristics of the
participants are described in Table 1.
Self-medication was prevalent in our study population with
316 out of 374 medical students (84.5%) and 90 out of 115
pharmacy students (78.3%) were using any of the drugs since the
start of pandemic. The most commonly utilized medications were
Paracetamol (65.2%), multivitamins (56.0%), Ibuprofen (29.0%),
Cetirizine (27.8%), and Azithromycin (25.6%) among others.
The reasons reported for usage of these medications included
cold/flu (71.4%), as preventive measures for COVID-19 (43.3%),
or a self-medication for COVID-19 symptoms (34.1%). However,
35.2% reported taking these medications without any reason
or symptoms, while another 40.1% consumed them regularly
for other reasons. The symptoms reported for self-medication
included fever (67.9%), fatigue (51.7%), cough (44.4%), sneezing
(40.7%), muscle pain/body aches (54.0%), nasal congestion
(42.1%), sore throat (46.6%) anosmia (23.1%), and breathing
difficulty (24.5%) as shown in Table 1. Paracetamol was the most
commonly used drug for all symptoms including fever, fatigue,
cough, sneezing, myalgia, nasal congestion, sore throat, anosmia,
and shortness of breath. Figure 1 demonstrates the relative
proportions of drug use for each specific symptomatology.
Paracetamol use was common in individuals >21 years,
final year medical students, those already infected with
COVID-19, and having flu, fever, and fatigue. 45.4% shown
all or most symptoms resolved with its use as shown
in Table 2. Azithromycin use was common in age >21
years, 5th year medical students, inhabitants of Khyber
Pakhtunkhwa/Balochistan, as well as those already infected
with COVID-19. Cetirizine use was frequent among pharmacy
students, final year medical students and those with self-reported
risk of COVID-19 infection. Use of antivirals was prevalent
among males of above 21 years of age. Use of multivitamins
was also common in individuals >21 years, females, residents
of Khyber Pakhtunkhwa/Balochistan and those either already

Sample Size/Sampling Technique
The sample size of the survey was obtained from the pilot study
determined using the power analysis. The minimum sample size
was 385, with a statistical power of 80% and a confidence interval
of 95%. We hypothesized that at least 50% of the participants
would practice self-medication, with a 5% margin of error.
The formula for sample size estimation was n = N ×/((N1) E2 + x), where N is the population size and n is sample
size estimation. A non-probability sampling technique was used
to recruit participants from social media platforms, including
WhatsApp, Facebook, and Messenger.

Inclusion/Exclusion Criteria
Inclusion criteria included completed responses, and the
respondent i.e., male or a female medical student pursuing MBBS
or Pharm D degree from a medical college in Pakistan, having
the ability to understand English, and being technologically adept
and have access to Internet. While exclusion criteria included
respondents from other than the medical field.

Ethical Approval
The study received ethical approval from the Institution’s
Ethics Committee of the Dow University Ojha Hospital. Each
participant had the right to withdraw from the study at any time.
The possible risks and the purpose of the survey were thoroughly
explained. Participants had to provide consent before filling out
the questionnaire.

Data Analysis
Microsoft Excel 2016 was used for data collection and assembled
in to Statistical Package for Social Sciences (SPSS) version 25.0
for data analysis. A multivariate analysis estimated the preference
of self-medication for the surveyed drugs using the baseline
demographics i.e., sex, age, marital status, educational status,
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TABLE 1 | Sociodemographic characteristic of medical students during the
COVID-19 lockdown (n = 489).

TABLE 1 | Continued
Variables

Variables
Age

Fatigue

253 (51.7)

18–20 years

286 (58.5)

Cough

217 (44.4)

21–25 years

192 (39.3)

Sneezing

199 (40.7)

>25 years
Gender

11 (2.2)

Male

108 (22.1)

Female

381 (77.9)

Student

Medical

374 (76.5)

Pharmacy

115 (23.5)

Medical year (n = 374)*

1st year

127 (34.0)

2nd year

77 (20.6)

3rd year

76 (20.3)

4th year

52 (13.9)

5th year

42 (11.2)

Sindh

237 (48.5)

Punjab

182 (37.2)

Khyber Pakhtunkhwa

61 (12.5)

State

Balochistan
Comorbidities
Self-reported health

Self-reported risk of
acquiring COVID-19

Present

22 (4.5)
467 (95.5)

Excellent

114 (23.3)

Good

296 (60.5)

Fair

72 (14.7)

Poor

7 (1.4)

No risk

75 (15.3)

Mild risk

186 (38.0)

142 (29.0)
125 (25.6)

Hydroxychloroquine

22 (4.5)

Doxycycline

19 (3.9)

Antivirals
Multivitamins

Symptomatology reported
for medicine use

43 (8.8)

Ivermectin
Cetirizine

Reason for use

319 (65.2)

Azithromycin

136 (27.8)
35 (7.2)
274 (56.0)

Others

56 (11.4)

Cold/Flu

349 (71.4)

Used it without having any
symptoms

172 (35.2)

Used it for prevention of
COVID-19 infection

212 (43.3)

Had COVID-19 symptoms
and I self-medicated

167 (34.1)

Had confirmed positive
COVID-19 infection and I
self-medicated

129 (26.4)

Consumed regularly for
other reasons

196 (40.1)

Others

155 (31.7)

Fever

332 (67.9)

206 (42.1)

Sore throat

228 (46.6)

Anosmia (loss of smell)

113 (23.1)

Breathing difficulty

120 (24.5)

Used it even though I had
none of the above
symptoms

173 (35.4)

Alleviated ALL the
symptoms

106 (21.7)

Alleviated MOST of the
symptoms

109 (22.3)

Alleviated A FEW of the
symptoms

91 (18.6)

Alleviated only ONE
symptom

85 (17.4)

Alleviated NONE of the
symptoms

98 (20.0)

DISCUSSION
Self-medication is often considered as an ambiguous
phenomenon and the practice is commonplace in developed
and developing countries alike. However, it has not been
extensively qualitatively or quantitatively studied, especially
in Pakistan (20). Self-medication with antibiotics rates were
generally low in middle income countries, according to a

(Continued)
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264 (54.0)

Nasal congestion

infected with COVID-19 or reported mild to severe risk of
acquiring infection. Individuals from province Punjab were more
likely to use ivermectin and less likely to use cetirizine as selfmedication. Doxycycline use was found prevalent in males. Use
of ivermectin was not shown to improve any of the self -reported
symptoms. Other medications were more common among those
having comorbid conditions and self-reported as fair/poor. All
these factors showed significant association when conducted on a
logistic regression model with reported odds ratios and p-values
as shown in Table 3.
The following variables were significantly associated
with self-medication practice in logistic regression
(Supplementary Figure 1; Table 4): female sex (p < 0.001),
third-year medical students (p = 0.022), self-reported health as
good (p = 0.029), and those previously infected with COVID-19
(p = 0.050). In multivariate analysis, female gender (<0.001),
those in third year of medical studies (p = 0.031) and those
students who perceived their self-reported health as “good” were
more likely to adopt self-medication practices (p = 0.032).

14 (2.9)

Ibuprofen

Muscle pain/Body aches

Data presented as frequency and percentage.
*Data retrieved for medical students only (n = 374).

214 (43.8)

Already infected

Paracetamol

Reporting of symptom
improvement after medicine
use

9 (1.8)

Absent

Severe risk
Use of medications

N (%)

N (%)
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FIGURE 1 | Relative proportions of drug use on specific symptomatology.

2020 review, however, among affected countries, Pakistan had
one of the highest prevalence of 81.23%, with only 7.3% in
Indonesia and 26.9% in Bangladesh (21). A study conducted by
the Aga Khan University, Karachi in 2008 revealed 76% selfmedication rates among the medical and non-medical university
students surveyed (22), while another survey from pre-COVID
times, consisting of a small segment of medical students in
Pakistan found 99% of them to be engaged in practicing
self-medication (23). To the best of our knowledge, our study

Frontiers in Public Health | www.frontiersin.org

is the first of its kind within the current pool of literature
available, that has evaluated self-medication among medical
students in the context of COVID-19, encompassing most
provinces of Pakistan.
The incidence of self-medication revealed in our results is
around 83%, a finding that is comparable to self-medication
occurrence rates during COVID-19 reported in studies
conducted abroad. Among the nursing undergraduates in Saudi
Arabia, self-medication practice with antibiotics and analgesics
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Factor

Parace-tamol
N = 319

Ibuprofen
N = 142

Azithro-mycin
N = 125

HCQ
N = 43

Iver-mectin
N = 22

Doxycycline

Cetirizine N
= 136

Antiviral
N = 35

Multi-vitamin
N = 274

Other
N = 56

Yasmin et al.
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TABLE 2 | Factors associated with self-medication of various drugs among medical students during the COVID-19 lockdown (n = 489).

N = 19
Age (years)
18–20

155 (48.6)

76 (53.5)

50 (40.0)

26 (60.4)

11 (50.0)

12 (63.2)

65 (47.8)

12 (34.3)

140 (51.1)

32 (57.1)

21–25 and above

164 (51.4)

66 (46.5)

75 (60.0)

17 (39.5)

11 (50.0)

7 (36.8)

71 (52.2)

23 (65.7)

134 (48.9)

24 (42.9)

Female

251 (78.7)

114 (80.3)

92 (73.6)

34 (79.1)

18 (81.8)

11 (57.9)

100 (73.5)

20 (57.1)

233 (85.0)

43 (76.8)

Male

68 (21.3)

28 (19.7)

33 (26.4)

9 (20.9)

4 (18.2)

8 (42.1)

36 (26.5)

15 (42.9)

41 (15.0)

13 (23.2)

Medical

244 (76.5)

109 (76.8)

95 (76.0)

34 (79.1)

17 (77.3)

15 (78.9)

95 (69.8)

27 (77.1)

209 (76.3)

44 (78.6)

Pharmacy

75 (23.5)

33 (23.2)

30 (24.0)

9 (20.9)

5 (22.7)

4 (21.1)

41 (30.1)

8 (22.9)

65 (23.7)

12 (21.4)

1st year

65 (26.6)

28 (25.7)

24 (25.3)

15 (44.1)

5 (29.4)

3 (20.0)

21 (21.6)

6 (22.2)

69 (33.0)

19 (43.2)

2nd year

49 (20.1)

22 (20.2)

15 (15.8)

6 (17.6)

2 (11.8)

3 (20.0)

24 (24.7)

4 (14.8)

40 (19.1)

13 (29.5)

3rd year

56 (23.0)

28 (25.7)

24 (25.3)

7 (20.6)

7 (41.2)

6 (40.0)

22 (22.7)

9 (33.3)

43 (20.6)

5 (11.4)

4th year

40 (16.4)

20 (18.3)

14 (14.7)

2 (5.9)

3 (17.6)

3 (20.0)

15 (15.5)

5 (18.5)

31 (14.8)

5 (11.4)

5th year

34 (13.9)

11 (10.1)

18 (18.9)

4 (11.8)

0 (0.0)

0 (0.0)

15 (15.5)

3 (11.1)

26 (12.4)

2 (4.5)

Sindh

154 (48.2)

76 (53.5)

43 (34.4)

19 (44.2)

5 (22.7)

6 (31.6)

71 (52.2)

17 (48.6)

129 (47.1)

26 (46.4)

Punjab

120 (37.6)

45 (31.7)

44 (35.2)

14 (32.6)

13 (59.1)

8 (42.1)

38 (27.9)

9 (25.7)

96 (35.0)

18 (32.1)

KPK and Balochistan

45 (14.1)

21 (14.8)

38 (30.4)

10 (23.2)

4 (18.2)

5 (26.3)

27 (19.9)

8 (22.6)

49 (17.9)

12 (21.4)

Gender

Student

Medical year

State
6
Comorbidities
Present

13 (4.1)

6 (4.2)

5 (4.0)

3 (7.0)

2 (9.1)

1 (5.3)

6 (4.4)

2 (5.7)

11 (4.0)

10 (17.9)

Absent

306 (95.9)

136 (95.8)

120 (96.0)

40 (93.0)

20 (90.9)

18 (94.7)

130 (95.6)

33 (94.3)

263 (96.0)

46 (82.1)

Self-reported health
63 (19.7)

33 (23.2)

24 (19.2)

11 (25.6)

2 (9.1)

3 (15.8)

24 (17.6)

8 (22.9)

53 (19.3)

7 (12.5)

Good

204 (63.9)

87 (61.3)

79 (63.2)

24 (55.8)

15 (68.2)

10 (52.6)

83 (61.0)

15 (42.9)

176 (64.2)

35 (62.5)

Fair/Poor

52 (16.3)

22 (15.5)

22 (17.6)

8 (18.6)

5 (22.7)

6 (31.6)

29 (21.3)

12 (34.3)

45 (16.4)

14 (25.0)

COVID-19 risk
March 2022 | Volume 10 | Article 803937

No risk

111 (34.8)

57 (40.1)

44 (35.2)

15 (34.9)

13 (59.1)

11 (57.9)

44 (32.3)

16 (45.7)

92 (33.6)

18 (32.1)

Already infected

63 (19.7)

19 (13.4)

36 (28.8)

7 (16.3)

2 (9.1)

1 (5.3)

22 (16.2)

2 (5.7)

68 (24.8)

11 (19.6)

Mild/Severe

145 (45.4)

66 (46.8)

45 (36.0)

21 (48.8)

7 (31.8)

7 (36.8)

70 (51.5)

17 (48.6)

114 (41.6)

27 (48.2)
27 (48.2)

Reason
Cold/Flu

263 (82.4)

53 (37.3)

31 (24.8)

10 (23.2)

5 (22.7)

1 (5.3)

53 (39.0)

10 (28.6)

18 (6.6)

No symptoms

90 (28.2)

28 (19.7)

16 (12.8)

11 (25.6)

7 (31.8)

1 (5.3)

10 (7.3)

1 (2.8)

81 (29.6)

2 (3.5)

COVID-19 prevention

79 (24.8)

24 (16.9)

21 (16.8)

12 (27.9)

6 (27.2)

2 (10.5)

6 (4.4)

1 (2.8)

71 (25.9)

6 (10.7)

COVID-19 symptoms

104 (32.6)

29 (20.4)

28 (22.4)

7 (16.3)

4 (18.2)

1 (5.3)

7 (5.1)

9 (25.7)

31 (11.3)

13 (23.2)
(Continued)
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Excellent

Factor

Parace-tamol
N = 319

Ibuprofen
N = 142

Azithro-mycin
N = 125

HCQ
N = 43

Iver-mectin
N = 22

Doxycycline

Cetirizine
N = 136

Antiviral
N = 35

Multi-vitamin
N = 274

Other
N = 56
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TABLE 2 | Continued

N = 19
COVID-19 positivity

92 (28.8)

23 (16.2)

38 (30.4)

6 (13.9)

6 (27.3)

2 (10.5)

5 (3.7)

6 (17.1)

60 (21.9)

16 (28.6)

Regular use

97 (30.4)

21 (14.8)

15 (12.0)

5 (11.6)

4 (18.2)

2 (10.5)

19 (14.0)

5 (14.3)

57 (20.8)

19 (33.9)

Others

105 (32.9)

45 (31.7)

17 (13.6)

12 (27.9)

10 (45.4)

3 (15.8)

15 (11.0)

4 (11.4)

16 (5.8)

9 (16.1)

Fever

303 (95.0)

73 (51.4)

32 (25.6)

8 (18.6)

3 (13.6)

2 (10.5)

3 (2.2)

4 (11.4)

12 (4.3)

13 (23.2)

Fatigue

189 (59.2)

43 (30.3)

14 (11.2)

6 (13.9)

4 (18.2)

1 (5.3)

1 (0.7)

2 (5.7)

69 (25.2)

12 (21.4)

Cough

112 (35.1)

30 (21.1)

46 (36.8)

7 (16.3)

3 (13.6)

1 (5.3)

27 (19.8)

3 (8.6)

1 (0.3)

23 (41.1)

Sneezing

96 (30.1)

18 (12.7)

15 (12.0)

8 (18.6)

3 (13.6)

1 (5.3)

73 (53.7)

4 (11.4)

4 (1.5)

14 (25.0)

Muscle pain

196 (61.4)

42 (29.6)

15 (12.0)

9 (20.9)

2 (9.1)

2 (10.5)

4 (2.9)

1 (2.9)

24 (8.8)

11 (19.6)

Nasal congestion

97 (30.4)

26 (18.3)

23 (18.4)

6 (13.9)

1 (4.5)

4 (21.1)

52 (38.2)

2 (5.7)

3 (1.1)

20 (35.7)

Sore throat

98 (30.7)

25 (17.6)

58 (46.4)

5 (11.6)

3 (13.6)

2 (10.5)

19 (14.0)

1 (2.9)

5 (1.8)

21 (37.5)

Anosmia

56 (17.5)

19 (13.4)

17 (13.6)

4 (9.3)

2 (9.1)

0 (0.0)

5 (3.7)

2 (5.7)

11 (4.0)

12 (21.4)

Breathing difficulty

63 (19.7)

21 (14.8)

15 (12.0)

6 (13.9)

4 (18.2)

3 (15.8)

4 (2.9)

3 (8.6)

15 (5.5)

9 (16.1)

No symptoms

110 (34.5)

31 (21.8)

9 (7.2)

9 (20.9)

6 (27.3)

2 (10.5)

8 (5.9)

6 (17.1)

81 (29.6)

6 (10.7)
12 (21.4)

Symptoms

Alleviated symptoms

7

All of them

76 (23.8)

30 (21.1)

24 (19.2)

9 (20.9)

2 (9.1)

3 (15.8)

28 (20.6)

8 (22.6)

59 (21.5)

Most of them

69 (21.6)

32 (22.5)

29 (23.2)

9 (20.9)

3 (13.6)

4 (21.1)

30 (22.0)

6 (17.1)

56 (20.4)

9 (16.1)

Few of them

58 (18.2)

26 (18.3)

19 (15.2)

7 (16.3)

2 (9.1)

4 (21.1)

24 (17.6)

7 (20.0)

54 (19.7)

12 (21.4)

One of them

55 (17.2)

25 (17.6)

25 (20.0)

8 (18.6)

3 (13.6)

3 (15.8)

25 (18.4)

5 (14.3)

50 (18.2)

13 (23.2)

None of them

61 (19.1)

29 (20.4)

28 (22.4)

10 (23.2)

12 (54.5)

5 (26.3)

29 (21.3)

9 (25.7)

55 (20.1)

10 (17.9)

Bold values signify significant p-value (<0.05) by either chi-square or Fisher’s exact test.
Data presented as frequency and percentage.
HCQ, hydroxychloroquine; KPK, Khyber Pakhtunkhwa.
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TABLE 3 | Bivariate analysis of the factors associated with the self-medication of various drugs during the COVID-19 lockdown among medical students (n = 489).
Variable

Parace-tamol

Ibuprofen

Azithro-mycin

HCQ

Iver-mectin

Doxy-cycline

Cetirizine

Antiviral

Multi-vitamin

Other

Age (years)
18–20

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

21–25 and above

3.554*

1.331

2.766*

0.931

1.432

0.815

1.829*

2.918*

2.025*

1.172

Female

1.136

1.220

0.723

1.078

1.289

0.321*

0.712

0.343*

2.573*

0.930

Male

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

Medical

1.001

1.022

0.965

1.078

1.048

1.159

0.636*

1.041

0.974

1.144

Pharmacy

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1st year

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

2nd year

1.669

1.414

1.038

0.631

0.651

1.676

2.286*

1.105

0.909

1.155

3rd year

2.671*

2.063*

1.981*

0.757

2.475

3.543

2.056*

2.709

1.095

0.400

4th year

3.179*

2.210*

1.581

0.299

1.494

2.531

2.046

2.145

1.214

0.605

5th year

4.054*

1.255

3.219*

0.786

–

–

2.804*

1.551

1.366

0.284

Gender

Student

Medical year

State
Sindh

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

Punjab

1.043

0.696

1.438

0.912

3.569*

1.770

0.617*

0.633

0.935

0.891

KPK/Balochistan

0.970

0.908

5.358*

1.564

2.812

2.962

1.468

1.570

1.953*

1.679

Present

0.760

0.913

0.850

0.761

2.235

1.188

0.972

1.315

0.776

7.627*

Absent

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

Comorbidities

Self-reported health
Excellent

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

Good

1.795*

1.022

1.365

0.826

2.989

1.294

1.299

0.294*

1.688*

2.143

Fair/Poor

1.559

0.947

1.447

1.055

3.784

3.041

1.611

0.512

1.523

3.524*
1.000

COVID risk
No risk

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

1.000

Already infected

4.872*

0.935

5.795*

1.366

0.424

0.249

1.604

0.339

12.882*

0.888

Mild/Severe

2.446*

1.357

0.848

1.556

0.561

0.669

2.080*

1.150

1.758*

0.505*

The dependent variable corresponds to the drug used while the reported p-values were obtained by logistic regression model, with the crude odds ratios reported.
P-values <0.05 have a *sign that indicates significant association with the dependent variable. Positive association implies to odds ratio >1.0 and negative association implies to odds
ratio <1.0.
HCQ: hydroxychloroquine; KPK: Khyber Pakhtunkhwa.

Paracetamol was the highest used drug in our study,
respondents 21–25 years and above, 5th year medical students,
those already infected with COVID-19, and stating symptoms
of cold/flu, fever and fatigue showed significant use. High
use of Paracetamol aligns with results from the nursing
undergraduates in Saudi Arabia (17) and from the Peru adult
population (16) where it was also the most consumed drug.
As a widely used first line pharmacotherapy analgesic for
tackling pain disorders and different pyrexia, Paracetamol use
is widely reported in studies comprising of medical students.
Health science major students in Nigeria commonly used
it as a pain reliever (25), while medical students in Iran
were also frequent users of this drug (27). An Indian study
found medical students to be more likely to self-medicate
than paramedical students and for this purpose, Paracetamol
was consumed mostly (28). Paracetamol has been known to
have negligible anti-inflammatory action (28) and guidelines

was found to be 87% (5) while In Kenya, health care selfmedication prevalence was 60.4% among healthcare workers,
indicating an increase from pre pandemic results (24). Another
study assessing self-medication prevalence in the Nigerian
population during the pandemic reported a finding of 41% (25).
In Togo, 34.1 % of the participants that belonged to healthcare,
air transport, police, road transport and informal sectors
reported to self-medicate and healthcare division had the highest
of 51.9% against all sectors (26). Conversely, in Peru, the number
of responders not engaging in self-medication was higher than
those that did, for all drugs including Acetaminophen, Ibuprofen,
Azithromycin, Hydroxychloroquine, Penicillin, Antiretrovirals,
which were evaluated (16). Multivariate logistic regression model
showed that being female gender, medical school year 3rd, having
been already infected with COVID-19 or having already infected
with COVID-19 were factors that were associated respondents
expected to self-medicate the most.
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TABLE 4 | Multivariate analysis of the factors associated with the self-medication practice during the COVID-19 lockdown among medical students (n = 489).
Factors

OR

95% CI

p-value

aOR

95% CI

p-value

Age (years)
18–20

1.000

-

-

1.000

-

-

21–25 and above

1.091

0.674–1.767

0.722

1.106

0.656–1.865

0.706

Female

2.547

1.531–4.239

<0.001*

2.810

1.630–4.843

<0.001*

Male

1.000

-

-

1.000

-

-

Medical

1.513

0.896–2.556

0.121

1.590

0.914–2.766

0.101

Pharmacy

1.000

-

-

1.000

-

-

Gender

Student

Medical year
1st year

1.000

-

-

1.000

-

-

2nd year

1.545

0.715–3.337

0.269

1.383

0.588–3.254

0.457

3rd year

3.003

1.175–7.677

0.022*

3.591

1.127–11.444

0.031*

4th year

1.655

0.669–4.093

0.276

1.517

0.435–5.289

0.513

5th year

1.094

0.453–2.644

0.842

1.034

0.278–3.849

0.960

State
Sindh

1.000

-

-

1.000

-

-

Punjab

0.796

0.485–1.306

0.366

0.685

0.402–1.168

0.164

KPK and Balochistan

2.166

0.878–5.344

0.094

1.862

0.737–4.705

0.189

Present

0.526

0.200–1.388

0.195

0.567

0.202–1.590

0.281

Absent

1.000

-

-

1.000

-

-

Comorbidities

Self-reported health
Excellent

1.000

-

-

1.000

-

-

Good

1.826

1.065–3.132

0.029*

1.853

1.053–3.261

0.032*

Fair/Poor

1.576

0.756–3.286

0.225

1.530

0.710–3.299

0.278

COVID risk
No risk

1.000

-

-

1.000

-

-

Already infected

2.230

0.999–4.980

0.050*

1.904

0.832–4.356

0.127

Mild/Severe

1.509

0.907–2.509

0.113

1.304

0.765–2.223

0.329

*Indicates significant association with the dependent variable (P < 0.05).
KPK, Khyber Pakhtunkhwa; COVID, coronavirus disease.

issued during the initial months of the pandemic state that
it can be used for treating mild COVID-19 symptoms when
managing patients at home (29) or for self-medication, especially
for fever or headache (30). This is consistent with our
results corresponding to Paracetamol use as it was greatly
used to treat “fever” in our study population, and its use
also showed improvement in all or most of the symptoms
experienced by the responders who employed Paracetamol.
However, some instances report the drug to be exacerbating
COVID-19 symptoms, likely due to activation of prothrombotic
mechanisms which is known as one of the leading pathogenic
causes of COVID-19 (29). Single or repeated high Paracetamol
dose, or chronic ingestion above therapeutic doses can result
in hepatotoxicity (17). Hepatotoxicity from intentional or nonintentional Paracetamol overdose is the most common cause
of drug-induced liver injury and is a global issue (17). The
medicine’s toxic dosage effects must be known to students
utilizing it.

Frontiers in Public Health | www.frontiersin.org

Multivitamins were the second highest consumed drug in our
study, which have also been the drug of choice as divulged in
a population-based survey during COVID-19 in Nigeria with
51.8% reporting to use this group of medicine (25). In Togo,
27.6% used Vitamin C when self-medicating (26), while in Egypt,
27% used vitamin C and 17.7% used vitamin D (31). A study
from 2015 involving healthcare and non-healthcare university
students from South India found multivitamins to be among
the most commonly self-medicated drugs (32). Multivitamins
include multiple vitamins and minerals, trace elements all of
which possess antioxidant properties and have a crucial role in
regulating immune function and can reduce risk of respiratory
infection (33). A large observational study conducted in US,
UK, and Sweden during first waves of COVID-19 demonstrated
a modest protective effect among those taking multivitamin
supplements with a reduced risk for testing positive for SARSCoV-2 (33). Hence, these might explain the significant use of
multivitamins by females and participants 21–25 years and above.
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fear and stigma, knowledge and access to prescription-only
medicines while trying to keep one’s health status, especially
if infected with COVID-19, could be accounted for selfmedication rates among the medical students’ community (26).
Furthermore, practicing self-medication allowed the students
to exercise freedom in managing their health and wellbeing
instilling a sense of independence (24). The overall high selfmedication rate throughout all year groups can be ascribed to
the extensive educational load upon these students and stressful
circumstances which results in distress and compels them to
seek OTC drugs (45). Another study conducted in Poland
highlighted such behaviors increased during lockdown (46).
According to a study from Jordan, factors such as female gender,
working in the medical field, and history of COVID-19 infection
were reportedly associated with self-medication similar to our
findings (47).
While the high self-medication percentage suggests medical
students’ confidence while self-prescribing, the possibility
that students’ knowledge about drug pharmacology, cultural
prevalence, and limited experience at the current student level
can make them susceptible to unfavorable outcomes, must not
be undermined (28). Drug addiction and drug dependence
(29) can also be induced by repeated self-medication, which
students must be aware of. Lockdown and isolation guidelines
have prevented the population from visiting hospitals and
clinics and have altered health-seeking behavior. As different
SARS-CoV-2 variants keep emerging, people are likely to selfmedicate (48). Medical students are also probable to keep selfmedicating, which could be helpful in obtaining benefits of
self-care, and alleviating burden on the healthcare system of
the country by reducing number of physician visits (49). By
practicing self-medication wisely themselves, staying mindful of
the pharmacological and taxological risks of improper drug use
(25), they could facilitate the lay population to treat themselves
for minor ailments which could further relieve pressure on health
care setups.
The study is important as questions specific to the drug
trends in the local population were incorporated, and responses
from all parts of the country were received. However, as
online platforms were used for disseminating the questionnaire,
students in remote areas with no access to the internet
could not be a part of the survey. Other limitation included
non-random sampling method and generalizability of study
results. Besides, due to recall bias, some responders might have
answered incorrectly.

Additionally, individuals with COVID-19 can experience weight
loss; having adequate amounts of vitamins and minerals can
prevent this unintended reduction in weight (34). Moreover,
a deficiency in certain micronutrients such as Vitamin A,
Vitamin D, Zinc can be deleterious during viral infections (33).
These factors might elucidate why those infected with COVID19 in our research resorted to a significantly high rate of
multivitamin use.
Ibuprofen was the third highest self-medicated drug in
our population. Previously, it has been reported to be the
most preferred NSAID for analgesic purposes among nursing
undergraduates in Saudi Arabia (20%) (17). As a nonsteroidal anti-inflammatory drug (NSAID), it is well tolerated
and effective during pain and inflammation and has minor
side effects (17). Alongside Paracetamol, it is one of the
most extensively used antipyretic (35). Since the start of
the pandemic, Ibuprofen use has been subject to debate
(36). Initially discouraged for use as it was suspected to
aggravate infections (37), such claims were later rejected. A
study analyzing data from ISARIC Clinical Characterization
Protocol UK cohort found NSAIDS use not disposing to
any poor COVID-19 outcome (38). A 2021 systematic review
and meta-analysis reiterated similar findings and revealed
no negative association between use of NSAIDS, including
Ibuprofen, with SARS-CoV-2 infection or its outcomes (39).
Ibuprofen has been known to have a better analgesic response
in men while higher threshold and greater tolerance for
electrically induced pain, responded significantly to ibuprofen
in contrast to women (40). Nevertheless, the high use of
this drug during COVID-19 can be linked to its efficacy in
relieving fever, infection (35). However, users must be wary that
disproportionate use of the drug can cause adverse drug reactions
(ADRs) (17).
Hydroxychloroquine and ivermectin, the sales of which
escalated globally in wake of COVID-19 were found to be
consumed in low amounts in our study (41). Other frequently
used drugs were Cetirizine and Azithromycin. Azithromycin has
been popular amongst antibiotics that have been used for selfmedication in Pakistan (21) and has also been an alternative for
self-medication in other countries such as Saudi Arabia (17) and
Peru (16). Using antibiotics during self-medication is the leading
cause of antimicrobial resistance (42) thus its intake must be
regulated, its appropriate use and disposal ensured especially by
medical students.
The most common reason for use of the respective drug
was “cold/flu”, consistent with results from studies of including
medical students from Iran (29, 43) and Brazil (44). “Fever”,
one of the most common COVID-19 symptom (19), followed
by “Muscle Pain” were the highest symptomologies reported
for medicine use. Analgesic use for muscular pain at any site
was also highly common among undergraduate medical and
paramedical students in India (28). Studies evaluating medical
students’ attitudes toward self-medication delineate sufficient
knowledge, familiarity with disease, and time constraints which
can also be cited as motives for self-medication among our
participants in this pandemic scenario (17). In the early days
of SARS-CoV-2 outbreak, when the disease was a source of
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CONCLUSION
Our study revealed common self-medication practices among
medical and pharmacy students. It is a significant health issue
especially during the pandemic times, with high consumption
reported as a prevention or treating symptoms of COVID19. Further measures are needed to improve healthcare
policies regarding awareness and sensitization about the
risks of self-medication. Future studies should also assess
students’ attitude toward self-medication, their knowledge
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